{"id":"5d66d040-8470-5f75-9411-3f56a4277763","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:pooled-trials-show-higher-ldl-cholesterol-at-low-dose","predicate":"increases","statement":"At relatively low total dosage the pooled mean difference in low-density lipoprotein cholesterol was +6.49 against control.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"ac928455-4db1-5a45-9739-23e1cc9e0982","mechanism_event_label":"At relatively low total dosage the pooled mean difference in low-density lipoprotein cholesterol was +6.49 against control.","subject":{"id":"e8eb9bb4-3c6f-5e96-a968-a6d1fece71e7","slug":"nattokinase-supplement","display_name":"Commercial nattokinase supplement, composition study-specific","entity_type_key":"chemical_species"},"object":{"id":"59b27f87-63a9-500e-9912-6c8863d9766b","slug":"blood-ldl-cholesterol","display_name":"Blood low-density lipoprotein cholesterol concentration","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"ac928455-4db1-5a45-9739-23e1cc9e0982","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:pooled-trials-show-higher-ldl-cholesterol-at-low-dose-event","event_type":"observed_intervention","label":"At relatively low total dosage the pooled mean difference in low-density lipoprotein cholesterol was +6.49 against control.","description":"Blood lipids","status":"provisional","compartment":null,"participants":[{"entity":{"id":"e8eb9bb4-3c6f-5e96-a968-a6d1fece71e7","slug":"nattokinase-supplement","display_name":"Commercial nattokinase supplement, composition study-specific","entity_type_key":"chemical_species"},"role":"acting component","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"59b27f87-63a9-500e-9912-6c8863d9766b","slug":"blood-ldl-cholesterol","display_name":"Blood low-density lipoprotein cholesterol concentration","entity_type_key":"cellular_process"},"role":"component the finding is about","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"duration","value_text":"Trial durations differ","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human, meta-analysis of randomized controlled trials","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Nattokinase supplementation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Wide interval (0.83 to 12.15). No significant difference at high dosage.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"Human, meta-analysis of randomized controlled trials","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"At relatively low total dosage the pooled mean difference in low-density lipoprotein cholesterol was +6.49 against control.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (2023) https://pubmed.ncbi.nlm.nih.gov/39076715/ DOI: 10.31083/j.rcm2408234","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vivo, oral","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Blood lipids","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"8f2e549a-85cf-5d63-adbc-aa9531f27dab","evidence_kind":"source_excerpt","locator":"Lines 1082-1082","start_line":1082,"end_line":1082,"excerpt":"At relatively low total dosage the pooled mean difference in low-density lipoprotein cholesterol was +6.49 against control.","model_system":"Human, meta-analysis of randomized controlled trials","directness":"reported_statement","verification_status":"source_derived_draft","notes":"","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"41cb127c-1c23-53aa-b7d0-5ec7f6fa3c99","stable_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","document_type":"imported_text","citation_label":"Original AI-assisted curation built from a supplied entity-first document of 105 entities and 129 claims. Every reference in that document was resolved against live PubMed with its abstract read and its DOI cross-checked on 2026-09-23, and the EFSA novel-food opinion was retrieved and read in full. That check corrected two PMIDs that pointed at unrelated papers, two DOIs, and two papers recorded as carrying no erratum that do carry one; it also reversed three findings the supplied document had stated backwards. Two papers carry a published correction, recorded as such and not as a retraction. Three sources are not indexed in PubMed and are cited by what they have. Laboratory lineages are recorded, so the four papers from one group, the three from another and the two readings of a single applicant dossier cannot be counted as separate lines of support. Study-specific doses, units, populations and limitations retained; activity units are never converted between systems. Not publisher full text.","file_path":"","sha256":"34fc46e0e849d06bfa13cb099a79b50679dd6fd0de8a5a0575326afdde3259c1","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}